▁Chron 9.296875
ic 0.548828125
▁pain 2.759765625
▁is 1.1630859375
▁always 6.859375
▁accompanied 4.84375
▁by 0.09686279296875
▁negative 5.1328125
▁emot 0.89794921875
ional 1.779296875
▁experiences 3.1875
▁and 2.34375
▁blocks 11.8359375
▁a 4.0390625
▁person 0.71630859375
’ 0.62109375
s 0.0005564689636230469
▁ability 0.75927734375
▁to 0.01343536376953125
▁receive 7.4765625
▁joy 2.98046875
▁and 1.4140625
▁satisfaction 4.1953125
▁from 1.07421875
▁life 0.51708984375
. 0.1646728515625
▁Chron 2.470703125
ic 0.001880645751953125
▁pain 0.0706787109375
▁is 1.27734375
▁still 8.6796875
▁considered 2.796875
▁to 1.8017578125
▁be 0.0308837890625
▁an 2.51953125
▁extreme 6.86328125
▁issue 5.546875
▁among 4.1796875
▁at 9.609375
▁least 0.1832275390625
▁ 0.33642578125
8 3.267578125
% 2.287109375
▁of 0.08209228515625
▁the 0.418701171875
▁residents 7.6796875
▁of 0.3779296875
▁progress 11.59375
ive 0.044952392578125
▁countries 0.51416015625
. 0.6494140625
▁The 2.34765625
▁research 5.0
▁investig 7.625
ates 0.53564453125
▁the 0.4970703125
▁development 6.15234375
▁of 0.2166748046875
▁de 6.52734375
pression 0.2337646484375
▁and 1.185546875
▁anx 0.72705078125
iety 0.0006327629089355469
▁among 1.673828125
▁patients 1.5556640625
▁receiving 6.08203125
▁ph 5.87890625
arma 3.162109375
ce 0.01751708984375
ut 9.500980377197266e-05
ical 0.00650787353515625
▁op 5.11328125
io 0.1064453125
ids 0.54345703125
▁and 2.279296875
▁medical 3.70703125
▁mar 1.9296875
iju 0.001544952392578125
ana 6.961822509765625e-05
▁( 2.541015625
MM 0.94873046875
) 2.125
▁as 2.623046875
▁severe 10.15625
▁pain 1.025390625
kill 3.09765625
ers 0.0007753372192382812
. 0.42529296875
▁The 1.44921875
▁introduction 8.765625
▁of 0.1732177734375
▁the 2.87890625
▁study 2.6640625
▁describes 3.53125
▁the 0.338134765625
▁apparent 10.640625
▁link 3.830078125
▁between 0.0977783203125
▁pain 2.52734375
▁and 0.356201171875
▁dem 9.3203125
oral 1.05078125
ization 0.11761474609375
. 1.068359375
▁There 4.54296875
▁is 1.0068359375
▁currently 5.984375
▁a 1.03515625
▁severe 5.375
▁lack 1.7509765625
▁of 0.0168304443359375
▁information 2.072265625
▁about 1.1396484375
▁the 0.44140625
▁effects 3.046875
▁of 0.052978515625
▁op 3.224609375
i 3.443359375
ates 0.014923095703125
. 3.865234375
▁It 3.361328125
▁comp 8.1875
ares 0.439453125
▁the 0.5341796875
▁effic 4.578125
acy 0.0017642974853515625
▁of 0.171875
▁pres 5.69921875
cri 2.587890625
ptions 1.837890625
▁and 1.7197265625
▁exam 5.48828125
ines 0.0167999267578125
▁the 0.41845703125
▁possibility 4.01171875
▁of 0.06536865234375
▁post 8.7109375
- 0.5947265625
tre 2.375
at 0.002735137939453125
ment 0.003711700439453125
▁de 1.4677734375
pression 0.043670654296875
. 1.1025390625
▁A 3.896484375
▁more 5.9765625
▁manage 8.9921875
able 0.0005178451538085938
▁and 2.5078125
▁sa 3.39453125
fer 6.473064422607422e-05
▁alternative 1.9921875
▁might 5.703125
▁be 0.214111328125
▁medical 2.17578125
▁mar 0.1961669921875
iju 0.000640869140625
ana 0.00012493133544921875
. 0.77392578125
▁They 7.1484375
▁manage 8.828125
▁pain 2.203125
▁successfully 6.00390625
, 1.5546875
▁but 0.93505859375
▁the 2.2890625
▁past 8.640625
▁few 2.72265625
▁dec 1.548828125
ades 0.00011742115020751953
▁indicated 8.28125
▁the 2.236328125
▁growing 4.984375
▁concern 3.322265625
▁regarding 2.9140625
▁op 3.794921875
iate 1.65625
▁ab 1.505859375
use 0.0110321044921875
▁in 3.94921875
▁forms 10.1015625
▁of 0.30908203125
▁over 3.76171875
d 0.154296875
ose 0.3212890625
▁and 0.7685546875
▁add 0.7890625
iction 0.020111083984375
. 0.11126708984375
▁However 4.3359375
, 0.005329132080078125
▁the 1.6455078125
▁legal 4.71875
▁status 2.5078125
▁and 3.38671875
▁novel 9.359375
ty 1.2998046875
▁of 0.1317138671875
▁this 4.4140625
▁drug 1.8515625
▁do 4.81640625
▁not 0.018402099609375
▁allow 0.72900390625
▁finding 7.42578125
▁a 2.2265625
▁large 3.158203125
▁number 0.78173828125
▁of 0.003688812255859375
▁studies 1.326171875
▁on 1.455078125
▁its 1.330078125
▁effect 2.501953125
iveness 0.362548828125
. 0.65673828125
▁Specifically 9.078125
, 0.054443359375
▁it 2.59765625
▁concerns 5.4375
▁the 0.82373046875
▁emot 5.8359375
ional 0.01824951171875
▁condition 4.30859375
▁of 0.258544921875
▁patients 0.708984375
▁experien 6.01953125
cing 0.00010919570922851562
▁chron 1.046875
ic 0.0005445480346679688
▁pain 0.0712890625
. 0.43701171875
▁This 3.10546875
▁research 1.865234375
▁paper 4.03125
▁a 2.166015625
ims 0.0006623268127441406
▁to 0.09088134765625
▁analyze 3.15625
▁levels 9.9296875
▁of 0.0248260498046875
▁de 0.51708984375
pression 0.0298614501953125
▁and 0.1685791015625
▁anx 0.02899169921875
iety 0.0003528594970703125
▁among 0.85009765625
▁people 2.6015625
▁receiving 2.310546875
▁ther 6.49609375
apy 0.0933837890625
▁by 4.546875
▁comparing 7.77734375
▁the 1.576171875
▁effects 2.052734375
▁of 0.030609130859375
▁ph 2.69140625
arma 0.0308837890625
ce 0.0022220611572265625
ut 3.5762786865234375e-05
ical 0.002979278564453125
▁op 0.12322998046875
io 0.442138671875
ids 0.03253173828125
▁and 0.25439453125
▁MM 0.6142578125
. 0.296630859375
▁The 1.4775390625
▁study 2.05859375
▁was 3.216796875
▁conducted 0.69189453125
▁in 1.3505859375
▁the 1.431640625
▁form 2.53125
▁of 0.0023136138916015625
▁collection 11.46875
▁and 0.73095703125
▁analysis 0.402587890625
▁of 0.014251708984375
▁statistical 3.58203125
▁data 0.149658203125
. 1.2353515625
▁The 0.92529296875
▁research 2.01171875
ers 2.01171875
▁used 1.5361328125
▁The 7.46875
▁De 2.751953125
pression 0.023681640625
▁Module 7.03125
▁of 1.056640625
▁the 0.2861328125
▁Pat 2.439453125
ient 0.006542205810546875
▁Health 0.04815673828125
▁Question 0.0218353271484375
naire 0.023345947265625
▁and 2.5078125
▁the 0.765625
▁General 1.001953125
ized 0.65673828125
▁An 0.005096435546875
x 8.416175842285156e-05
iety 0.0006151199340820312
▁Dis 0.2232666015625
order 0.0206451416015625
▁Sc 1.4853515625
ale 0.0037078857421875
▁to 1.2998046875
▁interview 8.0859375
▁participants 2.98828125
, 4.390625
▁evaluate 5.05859375
▁their 0.71630859375
▁answers 3.73046875
, 0.361572265625
▁and 0.04815673828125
▁conduct 4.66796875
▁the 1.9365234375
▁study 2.65625
. 0.10107421875
▁Part 5.5078125
icip 0.07110595703125
ants 0.043182373046875
▁were 0.873046875
▁rec 3.875
ru 0.001979827880859375
ited 0.00036144256591796875
▁for 4.3671875
▁six 6.5
▁months 0.286865234375
▁at 3.666015625
▁two 2.611328125
▁major 4.3515625
▁pain 2.4140625
▁relief 4.16015625
▁cent 0.8369140625
ers 0.037078857421875
▁in 0.5791015625
▁Israel 4.75390625
. 0.342041015625
▁To 5.0546875
▁specifically 10.15625
▁evaluate 3.0078125
▁and 4.8515625
▁compare 0.67041015625
▁the 0.393798828125
▁prob 10.015625
abilities 0.1014404296875
▁of 0.087158203125
▁de 0.8369140625
pression 0.045013427734375
▁or 4.37109375
▁anx 0.0484619140625
iety 0.0005331039428710938
▁among 1.3427734375
▁the 2.1171875
▁diverse 9.65625
▁groups 0.9677734375
, 0.7197265625
▁the 0.5615234375
▁study 2.22265625
▁used 1.525390625
▁multiple 5.37109375
▁log 0.7978515625
istic 0.0301666259765625
▁regression 0.2841796875
▁analysis 1.306640625
▁and 2.7734375
▁chose 8.3046875
▁medical 5.8125
▁mar 0.0943603515625
iju 0.0008797645568847656
ana 5.328655242919922e-05
▁as 0.5361328125
▁the 0.81005859375
▁control 2.453125
▁group 0.484619140625
. 0.2349853515625
▁This 3.498046875
▁type 4.62109375
▁of 0.00623321533203125
▁study 2.525390625
▁is 1.5126953125
▁the 3.6640625
▁most 1.3876953125
▁reve 8.234375
aling 0.0008883476257324219
▁and 1.5380859375
▁inclus 7.125
ive 0.00102996826171875
, 2.46875
▁as 1.41015625
▁it 0.289306640625
▁contains 5.04296875
▁direct 6.80078125
▁responses 5.51171875
▁from 0.84130859375
▁a 3.62109375
▁large 1.2216796875
▁number 0.50439453125
▁of 0.002925872802734375
▁participants 1.1201171875
. 0.68603515625
▁All 5.2578125
▁tools 8.09375
▁in 5.11328125
▁the 0.630859375
▁form 5.3203125
▁of 0.01947021484375
▁question 0.7216796875
na 0.00968170166015625
ires 0.00021409988403320312
▁and 1.5791015625
▁scales 2.96875
▁have 3.037109375
▁already 4.3828125
▁been 0.31640625
▁used 2.396484375
▁and 1.759765625
▁proved 2.634765625
▁their 1.43359375
▁effic 2.90625
acy 0.0023593902587890625
▁for 3.734375
▁collect 4.1015625
ing 0.0037784576416015625
▁analyt 7.31640625
ical 0.07525634765625
▁data 0.195068359375
. 0.37255859375
▁It 3.67578125
▁helps 4.1796875
▁to 0.62255859375
▁system 6.4375
at 0.5078125
ize 0.0019702911376953125
▁and 1.20703125
▁class 4.71484375
ify 0.0015134811401367188
▁distinct 8.3125
▁kinds 6.42578125
▁of 0.01751708984375
▁information 2.236328125
▁for 4.01953125
▁subsequent 4.87890625
▁un 8.515625
comp 3.943359375
licated 0.0200042724609375
▁services 12.421875
. 0.5478515625
▁Thus 4.76953125
, 0.01039886474609375
▁research 4.5625
ers 0.425537109375
▁can 1.720703125
▁compare 2.68359375
▁the 0.91259765625
▁effects 2.880859375
▁of 0.109130859375
▁medic 3.888671875
ations 0.72900390625
▁on 1.4365234375
▁patients 2.083984375
▁of 4.2421875
▁diverse 3.435546875
▁age 1.8935546875
▁groups 1.8779296875
, 0.845703125
▁background 4.08203125
s 0.1226806640625
, 0.020477294921875
▁physical 5.66796875
▁conditions 1.3955078125
, 0.040771484375
▁emot 6.3828125
ional 0.0295562744140625
▁states 1.2744140625
, 0.045013427734375
▁and 0.37646484375
▁so 2.755859375
▁on 0.1947021484375
. 0.0689697265625
▁The 1.0166015625
▁analysis 3.640625
▁of 0.99658203125
▁any 8.640625
▁human 6.90625
▁reaction 3.931640625
▁has 4.75390625
▁a 1.8466796875
▁high 3.052734375
▁potential 3.283203125
▁of 2.427734375
▁subject 4.01171875
iveness 3.751953125
▁and 1.162109375
▁bias 2.029296875
, 1.48828125
▁especially 2.8828125
▁regarding 3.619140625
▁people 4.8125
▁in 3.490234375
▁severe 2.439453125
▁pain 0.58544921875
▁and 2.373046875
▁un 5.67578125
stable 1.0380859375
▁emot 0.68115234375
ional 0.07916259765625
▁condition 2.505859375
. 0.061737060546875
▁Perhaps 8.8515625
▁some 5.22265625
▁patients 2.26171875
▁tend 4.59375
▁to 0.00965118408203125
▁ex 1.9384765625
agger 0.008819580078125
ate 0.0014476776123046875
▁their 0.98583984375
▁de 3.453125
press 1.6396484375
ive 0.058319091796875
▁state 2.4609375
▁or 1.6376953125
▁vice 5.54296875
▁vers 0.02081298828125
a 2.2411346435546875e-05
, 1.0908203125
▁de 7.22265625
- 2.609375
emph 0.460205078125
as 0.0027942657470703125
ize 0.06439208984375
▁serious 6.734375
▁difficulties 5.4921875
. 0.76220703125
▁Because 6.22265625
▁the 2.990234375
▁survey 4.84375
▁responses 6.7578125
▁were 1.560546875
▁thoroughly 8.390625
▁anonymous 2.90234375
, 0.277587890625
▁the 1.212890625
▁research 1.03515625
ers 0.2147216796875
▁were 2.375
▁unable 3.1015625
▁to 0.0013446807861328125
▁carefully 8.015625
▁analyze 2.74609375
▁each 2.38671875
▁patient 2.373046875
’ 0.5185546875
s 0.0008935928344726562
▁reaction 3.83984375
▁and 1.4326171875
▁compare 3.87109375
▁it 0.8818359375
▁to 0.52734375
▁the 0.99609375
▁actual 4.43359375
▁states 7.6640625
▁of 0.6669921875
▁condition 7.265625
. 0.383544921875
▁More 6.0234375
▁accurate 3.38671875
▁answers 4.37109375
▁could 1.9208984375
▁be 0.685546875
▁obtained 0.9345703125
▁by 1.4072265625
▁professional 6.015625
▁psych 1.078125
olog 0.37939453125
ists 0.0011491775512695312
▁via 7.19140625
▁personal 2.6953125
▁communication 4.15625
▁and 1.9521484375
▁behavior 6.2265625
al 0.2425537109375
▁analysis 2.01953125
. 0.30908203125
▁However 1.5634765625
, 0.0005164146423339844
▁this 1.591796875
▁method 2.224609375
▁of 2.451171875
▁research 1.9072265625
▁is 1.0029296875
▁way 6.3359375
▁more 0.90625
▁resource 4.578125
- 0.259521484375
int 1.283203125
ensive 0.02203369140625
▁and 0.424072265625
▁energy 10.6328125
- 0.0634765625
consum 0.34033203125
ing 0.0017805099487304688
. 0.7548828125
▁Part 6.23046875
icip 0.380126953125
ants 0.12396240234375
▁were 1.5263671875
▁rec 2.373046875
ru 0.0004901885986328125
ited 9.179115295410156e-06
▁for 1.6962890625
▁six 0.2305908203125
▁months 0.003910064697265625
▁at 0.27392578125
▁two 0.0469970703125
▁major 0.06683349609375
▁pain 0.026702880859375
▁relief 0.0232086181640625
▁cent 0.011138916015625
ers 0.0012445449829101562
▁in 0.039093017578125
▁Israel 0.01123809814453125
. 0.1734619140625
▁All 3.455078125
▁patients 2.251953125
▁experienced 4.74609375
▁chron 0.9169921875
ic 0.00019991397857666016
▁pain 0.1934814453125
▁for 2.494140625
▁at 0.669921875
▁least 0.0011949539184570312
▁ 1.8515625
3 1.521484375
▁months 0.264404296875
. 1.306640625
▁The 1.4296875
▁study 1.876953125
▁included 1.599609375
▁ 0.609375
8 3.015625
9 2.52734375
0 3.248046875
▁participants 1.5625
, 1.40625
▁of 2.56640625
▁which 0.447021484375
▁ 0.10064697265625
4 1.19921875
7 2.67578125
4 2.607421875
▁( 3.0859375
5 0.0885009765625
9 4.88671875
%) 0.7685546875
▁were 0.75390625
▁treated 3.11328125
▁sole 6.5078125
ly 6.0558319091796875e-05
▁with 0.263427734375
▁op 1.2978515625
io 0.3720703125
ids 0.12548828125
, 0.515625
▁ 0.779296875
3 1.2412109375
2 2.21875
9 2.462890625
▁( 0.047210693359375
4 2.486328125
1 1.095703125
%) 0.056793212890625
▁were 1.3935546875
▁treated 0.420166015625
▁with 0.40380859375
▁MM 0.6650390625
, 0.388427734375
▁and 0.0948486328125
▁ 0.2220458984375
7 2.0390625
7 2.357421875
▁( 0.1041259765625
8 1.94921875
. 0.92529296875
6 2.4453125
%) 0.0816650390625
▁acquired 10.671875
▁both 0.60009765625
▁( 4.69921875
Fe 9.578125
ing 1.552734375
old 0.307373046875
▁et 0.98046875
▁al 0.0242767333984375
., 0.170166015625
▁ 0.01149749755859375
2 0.00672149658203125
0 0.00023925304412841797
1 0.400390625
7 1.73046875
). 0.042236328125
▁The 1.0234375
▁remaining 7.9375
▁ten 6.71875
▁participants 1.44140625
▁who 4.765625
▁did 2.279296875
▁not 0.006542205810546875
▁receive 2.353515625
▁ph 3.96875
arma 0.08941650390625
ce 0.0008463859558105469
ut 3.2186508178710938e-06
ical 0.002155303955078125
▁op 1.28515625
io 0.054931640625
ids 0.02178955078125
▁and 2.482421875
▁medical 1.662109375
▁mar 0.0389404296875
iju 0.0002739429473876953
ana 4.3511390686035156e-05
▁were 0.487060546875
▁with 6.66015625
dra 0.059844970703125
wn 3.421306610107422e-05
▁from 0.253173828125
▁the 0.1795654296875
▁analysis 2.359375
▁in 4.9921875
▁the 1.2333984375
▁research 4.42578125
. 1.052734375
▁Therefore 4.8515625
, 0.017730712890625
▁it 3.640625
▁is 1.318359375
▁not 2.849609375
▁possible 0.7548828125
▁to 0.0084228515625
▁compreh 5.94921875
ens 0.1151123046875
ively 0.0162200927734375
▁compare 1.4814453125
▁patients 5.07421875
▁taking 3.6953125
▁medic 4.0625
ations 0.578125
▁with 1.4404296875
▁those 1.15625
▁who 0.7373046875
▁do 1.3203125
▁not 0.005035400390625
. 0.6337890625
▁The 1.4375
▁study 1.8974609375
▁conducted 4.37109375
▁a 1.845703125
▁correlation 6.40234375
▁type 9.2578125
▁of 0.27978515625
▁research 0.87451171875
▁with 3.458984375
▁variable 8.609375
▁measures 5.203125
. 0.97314453125
▁It 1.6806640625
▁evaluated 5.0859375
▁the 0.57177734375
▁inter 6.1328125
dep 2.32421875
end 0.00019109249114990234
ence 0.007038116455078125
▁of 0.576171875
▁various 3.322265625
▁factors 0.9873046875
▁that 2.85546875
▁affected 4.15625
▁the 0.41552734375
▁physical 6.41015625
▁and 0.292724609375
▁emot 0.5078125
ional 8.96453857421875e-05
▁condition 1.4208984375
▁of 0.050872802734375
▁patients 0.82763671875
▁experien 3.013671875
cing 1.0728836059570312e-06
▁chron 0.250244140625
ic 0.00021564960479736328
▁pain 0.0138397216796875
. 0.1357421875
▁For 4.25390625
▁example 1.1953125
, 0.0018100738525390625
▁the 1.142578125
▁survey 5.4921875
▁showed 3.96875
▁that 0.456787109375
▁the 1.8916015625
▁ratio 6.68359375
▁of 0.0714111328125
▁female 3.640625
▁patients 0.91796875
▁was 1.2822265625
▁remark 8.15625
ably 0.0001537799835205078
▁higher 0.1783447265625
▁in 2.37890625
▁the 0.46826171875
▁op 3.666015625
i 3.45703125
ates 0.01532745361328125
▁group 0.194580078125
▁compared 2.484375
▁to 0.0408935546875
▁the 0.603515625
▁MM 0.1650390625
▁group 0.33349609375
. 0.446533203125
▁In 3.46484375
▁turn 4.27734375
, 0.0012350082397460938
▁people 4.90625
▁on 4.73046875
▁op 3.08203125
i 0.64697265625
ates 0.0034389495849609375
▁were 0.97900390625
▁more 1.408203125
▁likely 0.2939453125
▁to 0.0288543701171875
▁report 2.8828125
▁major 6.046875
▁de 0.459228515625
press 0.6640625
ive 0.0023193359375
▁dis 0.9091796875
orders 1.5146484375
. 1.5576171875
▁The 1.7060546875
▁question 5.45703125
na 1.056640625
ires 0.00018203258514404297
▁used 2.576171875
▁different 6.85546875
▁variable 8.2109375
▁measures 0.346923828125
▁to 1.888671875
▁collect 2.640625
▁information 1.58984375
. 1.4951171875
▁For 1.677734375
▁example 0.2471923828125
, 0.0016660690307617188
▁it 3.880859375
▁included 2.013671875
▁compreh 8.2578125
ensive 0.046051025390625
▁so 5.24609375
cio 0.0009188652038574219
- 0.255859375
dem 0.11572265625
ographic 0.06719970703125
▁data 0.896484375
: 4.91015625
▁gender 1.99609375
, 0.039764404296875
▁age 0.275634765625
, 0.03790283203125
▁country 4.1953125
, 2.64453125
▁type 4.40625
▁of 0.0643310546875
▁residence 3.8359375
▁( 2.69140625
urban 0.71875
/ 1.3134765625
r 0.1632080078125
ural 0.0008549690246582031
), 0.1719970703125
▁years 6.2890625
▁of 0.1771240234375
▁education 0.80126953125
, 0.09088134765625
▁and 1.4638671875
▁employ 2.5390625
ment 0.0016765594482421875
▁status 0.64453125
. 0.1759033203125
▁Pat 4.6171875
ients 0.0821533203125
▁were 1.255859375
▁also 0.9453125
▁asked 0.5224609375
▁about 0.94189453125
▁their 0.6787109375
▁medical 2.498046875
▁history 0.525390625
▁over 8.53125
▁the 0.05792236328125
▁years 4.59765625
▁and 1.7255859375
▁the 1.494140625
▁current 2.9609375
▁presence 4.96875
▁of 0.08447265625
▁any 2.154296875
▁severe 3.716796875
▁dise 1.8251953125
ases 7.355213165283203e-05
▁such 4.33203125
▁as 0.0009732246398925781
▁heart 2.548828125
▁failure 1.826171875
, 0.286376953125
▁di 1.5517578125
ab 0.0006284713745117188
etes 0.0021228790283203125
, 0.06982421875
▁ar 4.08203125
th 0.1397705078125
rit 0.0249176025390625
is 0.00374603271484375
, 0.027557373046875
▁and 1.220703125
▁so 0.7744140625
▁on 0.04803466796875
. 0.0523681640625
▁The 1.44921875
▁third 6.9140625
▁measure 3.599609375
▁of 2.23046875
▁the 0.5302734375
▁question 1.9697265625
naire 0.275146484375
▁was 1.228515625
▁indicated 10.53125
▁by 1.2509765625
▁information 6.52734375
▁on 2.103515625
▁any 5.6171875
▁twelve 14.328125
- 0.2783203125
month 0.1571044921875
▁and 4.94921875
▁lifetime 0.6376953125
▁drug 3.24609375
▁and 1.6767578125
▁alco 0.130126953125
hol 6.628036499023438e-05
▁consumption 4.6640625
. 0.4248046875
▁Among 5.66015625
▁all 3.001953125
▁participants 1.970703125
▁in 3.78515625
▁the 0.19580078125
▁study 0.626953125
, 0.03887939453125
▁ 0.81689453125
4 2.08984375
2 2.3359375
. 1.28515625
2 2.228515625
% 0.05999755859375
▁suffered 4.83203125
▁from 0.043914794921875
▁de 1.6826171875
pression 0.2724609375
, 0.93115234375
▁and 1.3203125
▁ 0.1402587890625
3 1.5341796875
7 2.380859375
% 2.509765625
▁experienced 2.17578125
▁excess 6.75
ive 0.02423095703125
▁anx 0.29296875
iety 0.0018587112426757812
. 0.45849609375
▁In 3.0546875
▁addition 2.572265625
, 0.11346435546875
▁the 1.8994140625
▁record 10.3046875
▁included 3.67578125
▁a 2.83203125
▁pain 6.1796875
▁measurement 5.02734375
▁scale 0.92822265625
▁from 4.390625
▁ 0.463134765625
0 0.29541015625
▁to 0.202392578125
▁ 0.00577545166015625
1 0.069091796875
0 0.035125732421875
▁to 3.240234375
▁evaluate 1.4794921875
▁dis 5.796875
com 0.0723876953125
fort 0.0023059844970703125
▁feelings 8.0546875
▁during 4.20703125
▁the 0.288330078125
▁last 1.1162109375
▁month 1.7109375
. 0.219482421875
▁The 1.203125
▁pl 11.4296875
ur 1.4248046875
ality 0.0081787109375
▁of 0.07818603515625
▁de 3.68359375
press 1.1728515625
ive 0.019775390625
▁dis 2.5078125
orders 0.07489013671875
▁among 2.732421875
▁patients 0.931640625
▁in 2.798828125
▁the 0.322509765625
▁op 0.58740234375
i 0.44140625
ates 0.001613616943359375
, 9.1171875
▁medical 4.1328125
▁mar 0.026885986328125
iju 0.0006384849548339844
ana 2.9087066650390625e-05
, 0.27734375
▁and 0.10504150390625
▁mixed 1.638671875
▁OP 11.5234375
MM 4.2421875
▁groups 0.607421875
▁number 9.5234375
ed 0.0280303955078125
▁ 0.1966552734375
5 2.01171875
7 2.552734375
. 0.53662109375
1 2.43359375
%, 0.25048828125
▁ 0.006214141845703125
2 2.4453125
2 2.623046875
. 0.0928955078125
3 2.26171875
%, 0.0548095703125
▁and 0.072998046875
▁ 0.0019893646240234375
5 2.416015625
1 2.068359375
. 0.137939453125
4 1.794921875
%, 0.1641845703125
▁respectively 0.0194244384765625
. 0.279296875
▁The 1.2724609375
▁pl 5.06640625
ur 0.00994873046875
ality 4.565715789794922e-05
▁of 0.02557373046875
▁anx 0.453125
iety 0.012542724609375
▁contained 10.6875
▁ 0.250732421875
4 1.21484375
8 2.302734375
. 0.1539306640625
4 2.205078125
% 2.482421875
▁among 2.330078125
▁OP 4.84765625
▁patients 5.70703125
, 0.268798828125
▁ 0.08721923828125
2 1.0107421875
1 2.486328125
. 0.09600830078125
5 2.126953125
% 0.02569580078125
▁among 0.44580078125
▁MM 0.1109619140625
▁patients 0.34130859375
, 0.0200347900390625
▁and 0.01482391357421875
▁ 0.0247650146484375
3 1.4521484375
8 1.96484375
. 0.12286376953125
7 2.21875
% 0.0133209228515625
▁among 0.1832275390625
▁OP 1.8427734375
MM 0.13330078125
▁participants 3.404296875
. 0.2406005859375
▁Pat 4.2578125
ients 0.016265869140625
▁who 1.9873046875
▁took 2.1953125
▁strong 9.40625
▁op 0.759765625
i 0.822265625
ates 0.0030670166015625
▁were 1.318359375
▁t 10.09375
ended 1.0517578125
▁to 0.00782012939453125
▁place 9.4921875
▁their 1.7353515625
▁pain 0.53662109375
▁on 1.892578125
▁a 0.587890625
▁scale 1.5439453125
▁of 0.428955078125
▁ 0.10748291015625
9 2.697265625
▁to 2.138671875
▁ 0.01131439208984375
1 0.004856109619140625
0 0.00537872314453125
▁( 2.76171875
Fe 1.6201171875
ing 0.0021305084228515625
old 0.0003440380096435547
▁et 0.0150604248046875
▁al 0.00151824951171875
., 0.010009765625
▁ 0.0014162063598632812
2 0.000148773193359375
0 0.00014102458953857422
1 0.0025997161865234375
7 0.00785064697265625
). 0.010040283203125
▁They 4.015625
▁were 1.794921875
▁also 1.1572265625
▁an 9.546875
gu 4.73046875
ished 0.07342529296875
▁em 6.26171875
otion 0.0007801055908203125
ally 0.0007905960083007812
▁and 1.2001953125
▁react 7.578125
ed 0.0243682861328125
▁rad 9.140625
ically 0.0006270408630371094
▁neg 4.68359375
atively 0.0012950897216796875
▁to 0.1903076171875
▁almost 5.41796875
▁all 1.5791015625
▁survey 3.76171875
▁questions 0.24658203125
. 0.299072265625
▁One 5.8359375
▁of 0.43408203125
▁the 0.052947998046875
▁major 3.21875
▁limitations 3.431640625
▁is 3.31640625
▁the 0.5908203125
▁ins 4.65625
u 0.07391357421875
fficient 0.1181640625
ly 3.361328125
▁high 2.921875
▁response 2.853515625
▁rate 0.094482421875
, 2.447265625
▁ 4.46875
5 1.7861328125
7 2.533203125
% 2.205078125
▁instead 6.109375
▁of 0.00223541259765625
▁ 0.51025390625
7 1.609375
0 0.4150390625
% 1.5185546875
▁( 2.3984375
Fe 1.181640625
ing 0.0017499923706054688
old 0.0003025531768798828
▁et 0.0186920166015625
▁al 0.0009317398071289062
., 0.008636474609375
▁ 0.0020847320556640625
2 0.0001195669174194336
0 9.334087371826172e-05
1 0.0006814002990722656
7 0.006256103515625
). 0.0164642333984375
▁Pat 4.4609375
ients 0.057861328125
▁who 1.244140625
▁took 2.751953125
▁only 4.3671875
▁MM 0.77978515625
▁or 2.26171875
▁mixed 2.716796875
▁medic 1.66796875
ations 0.203125
▁course 13.15625
▁had 2.421875
▁a 0.97265625
▁significantly 2.8515625
▁more 4.6953125
▁stable 4.64453125
▁emot 0.9248046875
ional 0.0008778572082519531
▁state 0.603515625
▁and 1.236328125
▁cop 6.55078125
ed 0.05133056640625
▁with 0.359619140625
▁pain 0.82470703125
▁more 1.697265625
▁manage 6.61328125
able 1.3837890625
. 0.357177734375
▁It 2.6328125
▁can 3.046875
▁be 0.12744140625
▁fairly 8.3515625
▁explained 2.810546875
▁by 0.1590576171875
▁the 0.265625
▁weak 7.3984375
▁focus 7.921875
▁of 0.57421875
▁respond 8.609375
ents 0.082763671875
▁who 2.91015625
▁have 5.046875
▁overcome 7.69921875
▁severe 2.37109375
▁pain 1.1943359375
▁sens 6.66015625
ations 0.1837158203125
▁and 1.1650390625
▁de 4.6484375
press 0.72998046875
ive 0.051513671875
▁episodes 2.2109375
. 0.4609375
▁It 2.9453125
▁is 1.0458984375
▁not 2.732421875
▁clear 3.79296875
▁how 1.9375
▁to 3.123046875
▁use 4.17578125
▁these 2.361328125
▁statistics 4.36328125
, 3.171875
▁as 0.75048828125
▁they 1.783203125
▁still 5.23828125
▁may 5.25390625
▁be 1.0927734375
▁relevant 6.81640625
▁for 1.7685546875
▁the 2.091796875
▁overall 5.01953125
▁analysis 2.64453125
. 1.0634765625
